A Long-term Study of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN)
A Long-term Study of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN)
Active, not recruiting · NCT04204616 · Registry updated 2025-11-12Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Long-term Study of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN) | prurigo nodularis | Active, not recruiting | Phase 3 | 2025-11-12 | NCT04204616 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Galderma R&D | 23 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||